These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 31216849)
1. MicroRNAs in Cerebrospinal Fluid as Biomarkers in Brain Tumor Patients. Kopková A; Šána J; Večeřa M; Fadrus P; Lipina R; Smrčka M; Lojová M; Slabý O Klin Onkol; 2019; 32(3):181-186. PubMed ID: 31216849 [TBL] [Abstract][Full Text] [Related]
2. [Usage of Cerebrospinal Fluid for microRNA Analysis]. Kopková A; Šána J; Večeřa M; Knoflíčková D; Smrčka M; Slabý O; Fadrus P Klin Onkol; 2018; 31(Supplementum1):158-160. PubMed ID: 29808693 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors. Kopkova A; Sana J; Fadrus P; Slaby O Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858 [TBL] [Abstract][Full Text] [Related]
4. [Dysregulation of Long Non-coding RNAs in Glioblastoma Multiforme and Their Study Through Use of Modern Molecular-Genetic Approaches]. Večeřa M; Šána J; Bútová R; Reguli Š; Hermanová M; Křen L; Lipina R; Smrčka M; Slabý O Klin Onkol; 2018; 31(Supplementum1):168-170. PubMed ID: 29808696 [TBL] [Abstract][Full Text] [Related]
5. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection. Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193 [TBL] [Abstract][Full Text] [Related]
6. Use of Salivary MicroRNAs for Diagnosis of Solid Cancers. Kubíčková A; Slabý O Klin Onkol; 2018; 31(4):249-259. PubMed ID: 30541306 [TBL] [Abstract][Full Text] [Related]
7. [MicroRNAs in Prediction of Response to Radiotherapy in Head and Neck Cancer Patients - Pilot Study]. Ahmad P; Slavík M; Šána J; Hermanová M; Šlampa P; Smilek P; Kazda T; Slabý O Klin Onkol; 2018; 31(Supplementum1):137-139. PubMed ID: 29808687 [TBL] [Abstract][Full Text] [Related]
8. [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer]. Juráček J; Staník M; Peltanová B; Adamcová S; Doležel J; Fedorko M; Radová L; Slabý O Klin Onkol; 2018; 31(Supplementum1):155-157. PubMed ID: 29808692 [TBL] [Abstract][Full Text] [Related]
9. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies. Shalaby T; Grotzer MA Int J Mol Sci; 2015 Dec; 16(12):29103-19. PubMed ID: 26690130 [TBL] [Abstract][Full Text] [Related]
10. [Pilot Study on MicroRNAs as Biomarkers of Response to Sunitinib Treatment in Patients with Metastatic Renall Cell Carcinoma]. Kováčová J; Juráček J; Poprach A; Büchler T; Kopecký J; Fiala O; Svoboda M; Lojová M; Slabý O Klin Onkol; 2018; 31(Supplementum1):161-162. PubMed ID: 29808694 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis. Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W Cancer Sci; 2018 Sep; 109(9):2651-2659. PubMed ID: 29949235 [TBL] [Abstract][Full Text] [Related]
12. Utilization of Next Generation Sequencing in Analysis of Circulating MicroRNAs as Predictive Biomarkers for Patients with Locally Advanced Rectal Carcinoma. Macháčková T; Grolich T; Fiala L; Procházka V; Škrovina M; Kala Z; Slabý O Klin Onkol; 2019; 32(Supplementum1):157-159. PubMed ID: 31064188 [TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Teplyuk NM; Mollenhauer B; Gabriely G; Giese A; Kim E; Smolsky M; Kim RY; Saria MG; Pastorino S; Kesari S; Krichevsky AM Neuro Oncol; 2012 Jun; 14(6):689-700. PubMed ID: 22492962 [TBL] [Abstract][Full Text] [Related]
14. [Involvement of PIWI-interacting RNAs in Cancerogenesis via the Regulation of Gene Expression]. Rybecká S; Štítkovcová K; Vychytilová-Faltejsková P; Slabý O Klin Onkol; 2016; 29(6):428-438. PubMed ID: 27951720 [TBL] [Abstract][Full Text] [Related]
15. Expression and Functional Characterization of miR-34c in Cervical Cancer. Sommerová L; Fraňková H; Anton M; Jandáková E; Vojtěšek B; Hrstka R Klin Onkol; 2018; 31(Suppl 2):82-87. PubMed ID: 31023029 [TBL] [Abstract][Full Text] [Related]
16. Current Methods of microRNA Analysis. Bartošík M; Jiráková L Klin Onkol; 2018; 31(Suppl 2):93-101. PubMed ID: 31023031 [TBL] [Abstract][Full Text] [Related]
17. Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome. Pavelka Z; Zitterbart K; Nosková H; Bajčiová V; Slabý O; Štěrba J Klin Onkol; 2019; 32(1):70-74. PubMed ID: 30764633 [TBL] [Abstract][Full Text] [Related]
18. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma]. Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196 [TBL] [Abstract][Full Text] [Related]
19. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies. Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487 [TBL] [Abstract][Full Text] [Related]
20. Detection of EGFR Mutations in Circulating Tumor DNA (ctDNA) Retrieved from Plasma - Interlaboratory Quality Assessment in the Czech Republic. Linda Č; Markéta K; Ivana T; Eva P; Milada M; Hana V; Ondřej H; Karolína B; Jiří D; Monika B; Pavel D Klin Onkol; 2018; 31(5):353-360. PubMed ID: 30541321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]